Today: 30 April 2026
Microsoft stock price slides as OpenAI’s $110B funding deal puts the Azure tie-up back in focus

Microsoft stock price slides as OpenAI’s $110B funding deal puts the Azure tie-up back in focus

NEW YORK, Feb 27, 2026, 16:27 EST — After-hours

Shares of Microsoft Corp (MSFT.O) dropped 2.2% on Friday, finishing the regular session at $392.74, with after-hours moves showing barely any shift from that closing price, according to .

This matters: Microsoft’s stock now serves as a gauge for whether heavy AI investment actually delivers lasting cloud gains. Any change in the mechanics fueling that growth—whether it’s compute, partners, or distribution—often shows up right away in the share price.

Markets offered little relief. Nasdaq slipped 0.9%, a risk-off move as investors grappled with AI shakeups, lingering tariff questions, and persistent inflation. “We were reminded there are still some cracks out there,” said Carson Group strategist Ryan Detrick. Reuters

OpenAI is reportedly pulling in $110 billion in a fresh funding round, setting its valuation at a steep $840 billion and drawing heavyweight backing from Amazon (AMZN.O), Nvidia (NVDA.O), and SoftBank. In tandem, OpenAI and Amazon announced AWS will serve as the exclusive third-party cloud provider for OpenAI Frontier—an enterprise-focused platform for building and running AI “agents.” Microsoft’s Azure, however, isn’t losing its hold: it remains the sole cloud supplier for OpenAI’s APIs, the companies said. Reuters

Microsoft and OpenAI, in a joint statement Friday, described the development as incremental rather than transformative. The companies posted on Microsoft’s blog, emphasizing that “nothing” announced that day alters their current partnership. Azure, they confirmed, stays as the sole cloud platform for “stateless OpenAI APIs,” and OpenAI’s flagship offerings like Frontier aren’t leaving Azure anytime soon. The Official Microsoft Blog

In industry lingo, “stateless” covers single-shot requests with no lingering memory in the system between exchanges. An API, or application programming interface, is simply the channel developers rely on to slip those model calls into their apps and services.

OpenAI CEO Sam Altman, in making the funding announcement, framed the deals as a push for scale. “We are entering a new phase where frontier AI moves from research into daily use at global scale,” he said. AP News

The immediate issue for Microsoft investors: Which slice of the upcoming OpenAI-fueled workloads will actually land in Azure’s growth numbers, and which part gets logged outside, despite core API activity still running on Azure under the present agreements?

But things can flip in a hurry. Should AI demand taper off, or expenses for new capacity keep outpacing returns, investors may have less tolerance for the megacaps’ heavy spending. The cloud competition is also ramping up, as competitors introduce new chips, models, and enterprise packages.

Traders are eyeing specifics on OpenAI’s division of compute loads among its partners and the potential impact on cloud margins. Microsoft heads into its April 28 earnings call facing fresh scrutiny: investors want clarity on Azure’s growth and where the money’s landing in AI.

Stock Market Today

  • Biogen Shares Rise 6% After Q1 Earnings Beat Despite Guidance Cut
    April 29, 2026, 9:29 PM EDT. Biogen (NASDAQ: BIIB) shares rose 6% on Wednesday following its first-quarter 2026 earnings report. The biotech posted $2.48 billion in revenue, surpassing analyst expectations of $2.25 billion. Net income, excluding accounting standards (GAAP), increased 19% to over $529 million, or $3.57 per share, above forecasts of $2.95. Growth was driven by strong sales of Leqembi, for early Alzheimer's, up 74%, and the FDA-approved Skyclarys for Friedreich's ataxia. However, Biogen cut full-year adjusted net income guidance by $1 per share citing research and development charges. Revenue is expected to decline mid-single digits from 2025, excluding a pending $5.6 billion acquisition of Apellis Pharmaceuticals. Biogen's strategic shift towards high-potential therapies is underway despite cautious outlook.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Silver price today: XAG/USD jumps near $94 and SLV rallies — what traders watch next week
Previous Story

Silver price today: XAG/USD jumps near $94 and SLV rallies — what traders watch next week

Dell stock jumps 22% on AI server outlook and $10 billion buyback — what Wall Street watches next
Next Story

Dell stock jumps 22% on AI server outlook and $10 billion buyback — what Wall Street watches next

Go toTop